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Background: The type III secretion (T3S) chaperone Scc4 modulates Chlamydia RNA polymerase holoenzyme activity and
is also required for secretion of the gatekeeper CopN.
Results: Interactions between the Scc4 and Scc1 chaperones and CopN are characterized.
Conclusion: Scc4 forms a ternary complex with Scc1 and CopN to promote CopN secretion during infection.
Significance: Scc4 is an important link between the T3S system and transcription.
Secretion of effector proteins into the eukaryotic host cell is
required for Chlamydia trachomatis virulence. In the infection
process, Scc1 and Scc4, two chaperones of the type III secretion
(T3S) system, facilitate secretion of the important effector and
plug protein, CopN, but little is known about the details of this
event. Here we use biochemistry, mass spectrometry, nuclear
magnetic resonance spectroscopy, and genetic analyses to characterize this trimolecular event. We find that Scc4 complexes
with Scc1 and CopN in situ at the late developmental cycle of
C. trachomatis. We show that Scc4 and Scc1 undergo dynamic
interactions as part of the unique bacterial developmental cycle.
Using alanine substitutions, we identify several amino acid residues in Scc4 that are critical for the Scc4-Scc1 interaction,
which is required for forming the Scc4䡠Scc1䡠CopN ternary complex. These results, combined with our previous findings that
Scc4 plays a role in transcription (Rao, X., Deighan, P., Hua, Z.,
Hu, X., Wang, J., Luo, M., Wang, J., Liang, Y., Zhong, G., Hochschild, A., and Shen, L. (2009) Genes Dev. 23, 1818 –1829), reveal
that the T3S process is linked to bacterial transcriptional events,
all of which are mediated by Scc4 and its interacting proteins. A
model describing how the T3S process may affect gene expression is proposed.
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Chlamydia spp. are obligate intracellular bacteria that cause
a variety of diseases in humans. Chlamydia pneumoniae produces bronchitis and atypical pneumonia and has been linked
to atherosclerosis (1). Chlamydia trachomatis serovars A–C
are the leading causes of preventable blindness (trachoma),
whereas serovars D–K and L1–L3 produce the most common
bacterial sexually transmitted diseases. The deleterious effects
of infection and the commensurate cost of treatment make
these pathogens a significant public health concern worldwide
(2). Chlamydia spp. have a unique developmental cycle, altering between infectious elementary bodies (EBs)4 and metabolically active reticulate bodies (RBs) (3, 4). The entire cycle takes
⬃48 –72 h to complete in cultured epithelial cells. Shortly after
invasion, EBs reside within a membrane-bound vacuole in the
host cell, called an inclusion, and subsequently differentiate
into RBs. RBs then undergo active replication and macromolecule synthesis. At ⬃24 h postinfection (hpi), RBs asynchronously differentiate to EBs. Finally, EBs exit the host cell to
infect adjacent cells. The growth of C. trachomatis can be
divided into early (EB-to-RB transition), middle (RB replication), and late stages (RB-to-EB transition and preparation for a
subsequent infection cycle) of development (5, 6).
Numerous Gram-negative bacteria in the genera of Yersinia,
Salmonella, Escherichia coli, Salmonella, Shigella, Vibrio, Pseudomonas, and Chlamydia employ a T3S system to inject effectors across host membrane barriers (7–11). Expression of the
T3S system, its assembly into a highly ordered structural apparatus, and its activation are spatiotemporally regulated (12–15).
The T3S apparatus assembles in the following order: a basal
body, a “needle” extending from the bacterial surface, and the
pore-forming translocon, which is a docking site for the needle
4

The abbreviations used are: EB, elementary body; RB, reticulate body; IFA,
indirect immunofluorescence assay; hpi, hours postinfection; T3S, type III
secretion; RNAP, RNA polymerase; TEV, tobacco etch virus protease; IPTG,
isopropyl-1-thio-␤-D-galactopyranoside; HSQC, heteronuclear single
quantum coherence; DSP, dithiobis(succinimidyl propionate); Tricine,
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; BTH, bacterial two-hybrid; RMSD, root mean square deviation; NTD, N-terminal domain; NTA,
nitrilotriacetic acid.
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tip on the host membrane (7). Once the T3S apparatus is assembled, translocators (translocon subunits) and effectors are then
secreted. Many T3S effectors require cognate chaperones for
proper secretion because they are translocated in an unfolded
form (12, 14, 16). These chaperones serve to prevent untimely
effector translocation. Several T3S chaperones have also been
shown to regulate T3S gene expression (12, 13, 17–19). Despite
conserved protein composition in the T3S apparatus, diverse
effectors, chaperones, and regulators are found in various bacteria, reflecting the unique niche of each bacterial species.
There has been little progress toward understanding exactly
how specific effectors are paired with their chaperones and
delivered to the T3S system apparatus for secretion, although
this is a fundamental aspect of T3S system function.
The T3S system is a key pathogenic attribute of Chlamydia
spp., in which ⬃80 different T3S effectors are predicted to be
secreted into the host cytosol to modulate host function for
survival and development (8, 20, 21). There are three classes of
T3S chaperones in Chlamydia spp. (8, 22–27). The class I chaperones include class Ia chaperones (Scc1 and Scc4 or CT663),
which bind to just one effector, and class Ib chaperones (Slc1,
Mcsc, and CT584), which bind to multiple effectors. Class II
chaperones (Scc2 and Scc3) interact with translocators. The
class III chaperones (CdsE and CdsG) interact with proteins
comprising the needle. Whereas most T3S effectors require
only one chaperone, the chlamydial CopN, that is homologous
to the Yersinia gatekeeper or “plug” protein YopN/TyeA, binds
to the Scc1, Scc4, and Scc3 chaperones (23, 27, 28). Through a
central domain, CopN interferes with microtubule networks
(29, 30). CopN protein also contains two chaperone binding
domains at its opposite termini: the N-terminal chaperone
binding domain binds with the Scc1 and Scc4 chaperones, and
the C-terminal chaperone binding domain binds to a translocator-specific Scc3 chaperone (23, 27, 31). Biochemical studies
and secretion assays in Yersinia indicate that the C. pneumoniae Scc4 and Scc1 chaperones promote CopN secretion,
and the Scc3 chaperone represses its secretion (23). It remains
unclear how such seemingly disparate chaperone-CopN interactions are utilized during chlamydiae infection.
We have previously discovered that C. trachomatis CT663
(hereafter referred to as Scc4) serves as a transcriptional regulator (17) in addition to being a T3S chaperone. Unlike most
previously described bacterial transcriptional regulators (with
the exception of bacteriophage T4 AsiA protein) (32), C. trachomatis Scc4 targets region 4 of 66 and the flap domain of the
RNA polymerase (RNAP) ␤ subunit in the context of the RNAP
holoenzyme. The 66RNAP transcribes the majority of the
housekeeping genes, including T3S system genes, in C. trachomatis (33, 34). We hypothesize that Scc4, through specific
interaction with the 66RNAP holoenzyme, plays a crucial role
in facilitating a global change in gene expression involved in
regulating the T3S process during C. trachomatis infection.
Understanding the dynamic interactions between T3S chaperones and their binding partners is a necessary step toward
elucidating the regulated T3S process. Here, using biochemistry, quantitative mass spectrometry, NMR spectroscopy, and
genetic approaches, we characterize the fundamental functionality of T3S chaperones using C. trachomatis Scc4, Scc1, and
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CopN as a model for chaperone-effector interactions. Combined with our previous results (17), we now demonstrate a
dual role for C. trachomatis Scc4 as a necessary part of the
Scc4䡠Scc1䡠CopN complex and also as a participant in RNA transcription through its binding to the 66RNAP holoenzyme. Our
data extend the understanding of the role of Scc4 and Scc1
chaperones in CopN recognition and, importantly, provide a
new paradigm for strict control of T3S system action that is
mediated by Scc4 to ensure that the T3S system appropriately
functions in response to developmental and environmental
cues.

Materials and Methods
Molecular Cloning—The pETDuet-1TEVSiteHis6 derived
from pETDuet-1 (Novagen) encodes a hexahistidine (His6) tag
that is removable with tobacco etch virus protease (TEV) cleavage. The Scc1 coding region was amplified from genomic DNA
of C. trachomatis serovar F/IC-Cal-3 (ATCC VR-346) by PCR
and cloned into the NcoI/XhoI sites of pETDuet-1TEVSiteHis6
to yield pDuetScc1-His6. The PT7-Scc1 fragment from pDuetScc1-His6 was then subcloned into pACYC184 to generate
pACYCScc1-His6. The Scc4 sequence from pHis663 (17) was
subcloned into the NcoI/XhoI sites of pET28a (Novagen) to
obtain pET28-Scc4. Similarly, the Scc4 sequence was cloned
into pCDFlac (35) to yield pCDFScc4. A synthesized gBlock
fragment (Integrated DNA Technologies) containing multiple
mutations in Scc4 was cloned into pCDFScc4 at the NcoI/XhoI
sites to generate pCDFScc4_6A. The BamHI/SphI fragment
from pCDFScc4_6A was subcloned into the BamHI/SphI sites
of pCDFScc4, resulting in pCDFScc4_4A. A PCR fragment containing a single point mutation in Scc4 was cloned into pCDFScc4 to yield pCDFScc4_95A. Plasmids encoding fusion proteins of the N-terminal domain of RNAP ␣ subunit from E. coli
(␣-NTD) and Scc1, Scc4, or CopN were constructed by inserting the gene of interest into the NotI/SpeI sites of pRBR (17).
Plasmids encoding the fusion protein of a DNA binding domain
(CI) and Scc1 or Scc4 were created by inserting the gene of
interest into the NotI/SpeI sites of pRAC (17). The identity of all
constructs was confirmed by restriction enzyme mapping and
DNA sequencing.
C. trachomatis Infection and Microscopy Analysis—Human
cervix adenocarcinoma HeLa cells (ATCC CCL-2.1) were cultured in Dulbecco’s modified Eagle’s medium with high glucose
(4.5 g/liter) supplemented with 10% fetal bovine serum (Sigma)
and L-glutamine (2 mM) at 37 °C in a humidified incubator with
5% CO2. For the indirect immunofluorescence assay (IFA), a
HeLa monolayer grown on 12-mm diameter glass coverslips in
24-well plates was inoculated with C. trachomatis serovar
F/Cal-I-13 with a dose that results in infection of ⬃50% of cells.
The plates were then centrifuged at 1600 ⫻ g for 40 min at
37 °C. Infected cells were cultured in medium containing 1
g/ml cycloheximide at 37 °C for various times as indicated
under “Results.” After fixing with 2% paraformaldehyde and
permeabilizing with 4% saponin, cells were subjected to immunostaining with antibodies overnight at 4 °C. Cells were then
incubated with Alexa 568-conjugated (red) or FITC-conjugated (green) secondary antibodies (Molecular Probes) for 45
min at 37 °C. Cells were counterstained with 4⬘,6-diamidino-2VOLUME 290 • NUMBER 47 • NOVEMBER 20, 2015
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phenylindole dihydrochloride (DAPI). Images were obtained
with a fluorescence microscope (Zeiss) and processed using
AxioVision software.
Antibodies—A rabbit polyclonal antibody against CI and a
mouse polyclonal antibody against Scc4 were described previously (17). A mouse polyclonal antibody against Scc1 and a
rabbit polyclonal anti-Scc4 antibody were kindly provided by
Guangming Zhong (University of Texas, San Antonio, TX).
Rabbit polyclonal antibodies against Scc1, Scc3, or CopN were
kindly provided by Dr. Ken Fields (University of Kentucky) (28).
Generation and Purification of Recombinant Proteins—
Recombinant Scc4 and Scc1 with a His6 tag at its C terminus
(Scc1-His6) were expressed in E. coli RosettaTM (DE3)pLysS
cells harboring pET28-Scc4 or pCDFScc4 and/or pACYCScc1His6. Cells were grown in LB broth at 37 °C to A600 ⫽ 0.8, and
then protein expression was induced by the addition of isopropyl-1-thio-␤-D-galactopyranoside (IPTG) to a final concentration of 0.5 mM. 15N-Labeled proteins were expressed similarly
in minimal media (36) containing 0.1% [15N]ammonium chloride. After a 3-h incubation at 37 °C, the cells were harvested by
centrifugation. The cells in 20 mM Tris (pH 8.0), 150 mM NaCl,
15 mM imidazole, and 5% glycerol supplemented with DNase I
(Roche Applied Science), RNase A (Sigma), and EDTA-free
protease inhibitor were lysed using an Emulsiflex C5 homogenizer (Avestin). Cleared lysate obtained by centrifugation at
184,250 ⫻ g for 45 min was then loaded onto a 5-ml His-Trap
HP column (GE Healthcare) (at 4 °C). The column-bound proteins were eluted with 20 mM Tris (pH 8.0), 150 mM NaCl, 5%
glycerol, and 300 mM imidazole and dialyzed overnight against
20 mM Tris (pH 7.6), 100 mM NaCl, and 5% glycerol. Proteins
were then concentrated to ⬃8 ml and loaded onto a HiLoad
26/60 Superdex 75 (GE Healthcare) for gel filtration purification. The purification of tag-free Scc4 protein was performed
using anion exchange chromatography (Source Q, GE Healthcare), followed by gel filtration purification as described previously (17).
The GST-tagged CopN and GST-tagged Scc3 proteins were
expressed in E. coli XL1-blue cells. Protein expression was
induced by adding IPTG to a final concentration of 0.1 mM.
Harvested cells were resuspended in 10 mM Na2HPO4, 1.8 mM
KH2PO4 (pH 7.4), 150 mM NaCl, and 2.7 mM KCl and lysed
using an Emulsiflex C5 homogenizer. The cleared lysates were
incubated with glutathione-Sepharose (GE Healthcare) for 2 h
at 4 °C. After extensive washing with PBS to remove unbound
proteins, bound proteins were eluted with 10 mM reduced glutathione. Eluate was dialyzed against 20 mM Tris (pH 8), 150 mM
NaCl, and 10% glycerol.
The Scc1-His6 used in the NMR experiments was purified
under denaturing conditions and refolded on the HisTrap column. Briefly, harvested cells were suspended in BugBusterTM
protein extraction reagent supplemented with 6 M urea and
lysed by sonication at 30% power for 120 s (3 ⫻ 30 s on/10 s off).
Cleared cell lysate was loaded onto a 3-ml column containing
Ni2⫹-Sepharose fast flow media (GE Healthcare) and washed
with 20 mM sodium phosphate (pH 8.0), 300 mM NaCl, 20 mM
imidazole, 6 M urea. The column-bound Scc1-His6 protein was
refolded using a linear gradient from 6 to 0 M urea (30 ml total at
NOVEMBER 20, 2015 • VOLUME 290 • NUMBER 47

0.1 ml/min) and eluted with 20 mM sodium phosphate (pH 8.0),
300 mM NaCl, and 300 mM imidazole.
Analytical Gel Filtration—Gel filtration analysis of N-terminal His6-tagged Scc4 (His6-Scc4) and the Scc4䡠Scc1-His6 complex was conducted under different buffer conditions as indicated under “Results.” Standard curves were produced using
each buffer and a protein molecular weight standard mixture
(bovine serum albumin (BSA), ␤-lactoglobulin, cytochrome c,
and cytidine). Linear regression analysis was used to determine
best-fit line equations, which were then used to calculate the
apparent molecular weights of samples. For this study, either a
HiPrep Sephacryl S-100 HR column (1 ml sample injection volume, 1.5 ml/min flow rate) or an ENrich 70 SEC column (50 l
sample injection volume, 1.0 ml/min flow rate) was used with a
Bio-Rad Duoflow F10 work station.
Competition-based Protein Binding Assay and Quantitative
Mass Spectrometry Analysis—Purified [15N]Scc4 was incubated with purified Scc4䡠Scc1-His6 complex in buffer containing 20 mM Tris (pH 7.6), 100 mM NaCl, and 5% glycerol at a ratio
of 2:1 or 10:1 ([15N]Scc4/Scc4䡠Scc1-His6 complex) for 0.5 and
2.0 h. Free Scc4 was then separated from the complex using a
5-ml HisTrap HP column. After extensive washing, the bound
complex was eluted with 20 mM Tris (pH 8.0), 150 mM NaCl, 5%
glycerol, and 300 mM imidazole. The eluate was dialyzed overnight against 20 mM Tris (pH 7.6), 100 mM NaCl, and 5% glycerol and then concentrated with a 5,000 molecular weight cutoff Amicom filter (Millipore). Concentrated proteins were then
subjected to trypsin digestion and LC/MS analysis to determine
the amount of [15N]Scc4 that had incorporated into the
Scc4䡠Scc1-His6 complex. A Thermo Fisher LTQ XL linear ion
trap mass spectrometer coupled to an Eksigent nanoLC 2D system and equipped with a PicoFrit ProteoPep II C18 column
(New Objective) was used.
NMR—Purified [15N]Scc4 was prepared for NMR analysis by
buffer exchanging into 20 mM ammonium acetate (pH 5.5)
using a 3,000 molecular weight cut-off centrifugal filter. This
buffer was chosen based on screening conditions for gel filtration and NMR analysis. As shown under “Results,” the
Scc4䡠Scc1 heterodimer is present in 20 mM sodium acetate
buffer at pH 4.5 without higher order oligomers. Because Scc4
is unstable in this buffer, 20 mM ammonium acetate at pH 5.5
was screened and gave good NMR peak dispersion and uniformity, indicating that Scc4 was folded and stable in this
buffer. [15N]Scc4 (0.5 mM) was analyzed on a Varian 700-MHz
spectrometer with 10% D2O to provide a lock signal. A 1H-15N
heteronuclear single quantum coherence (HSQC) spectrum
was collected by signal-averaging eight scans and collecting 128
increments in the indirect dimension. Data were processed
with a sine bell weighting function in both dimensions using
NMRPipe software (37) and visualized with NMRView software (One Moon Scientific) (38). Refolded Scc1-His6 protein
was added to the [15N]Scc4 sample in a 1:1 molar ratio. The
sample volume was reduced using a centrifugal filter to obtain
0.5 mM [15N]Scc4䡠Scc1-His6 in 10% D2O for NMR analysis. A
1
H-15N HSQC spectrum was collected using the same conditions as described above.
His6-mediated Pull-down Assay—Purified Scc4䡠Scc1-His6
complex bound to 100 l of Ni2⫹-NTA beads (Pierce) was
JOURNAL OF BIOLOGICAL CHEMISTRY

28143

Type III Secretion Effector-Chaperone Recognition
added to purified GST-tagged CopN and/or GST-tagged Scc3
in a total volume of 0.3 ml in 20 mM Tris (pH 8.0), 150 mM NaCl,
and 10% glycerol. Ni2⫹-NTA beads added with GST protein
were used as a negative control. After overnight incubation at
4 °C, the beads were washed extensively using 20 mM Tris (pH
8.0), 150 mM NaCl, and 10% glycerol. The captured proteins
were eluted with 10 mM glutathione. Proteins were separated by
12% SDS-PAGE and then transferred to Immobilon-P membranes. Immunoblotting was performed using antibodies
against Scc4, Scc1, Scc3, and CopN, as described previously
(39). Blots were developed using horseradish peroxidase-conjugated secondary antibodies (Sigma) and the SuperSignal
chemiluminescent detection kit (Pierce).
Cross-linking, Immunoprecipitation, Co-immunoprecipitation, and Immunoblotting—A vapor glutaraldehyde cross-linking assay was performed to ascertain the oligomeric state of
Scc4 in vitro using the method described previously (40). For in
situ protein cross-linking, HeLa cells in four 162-cm2 flasks
were infected with C. trachomatis serovar F/Cal-I-13 using a
dose that results in 95% of cells being infected. The cells were
harvested at 36 hpi in PBS (pH 7.4) and cross-linked for 60 min
at 4 °C using the cross-linker dithiobis(succinimidyl propionate) (DSP) (Pierce) at a final concentration of 2 mM (diluted
from a 40 mM stock solution in dimethyl sulfoxide) as described
previously (41). Cross-linking was quenched by adding TrisHCl (pH 8.0) to a final concentration of 50 mM (at 25 °C). Cells
were then solubilized on ice for 20 min in 1% Nonidet P-40,
0.1% SDS, 10 mM HEPES (pH 7.8), 10% glycerol, and 150 mM
NaCl containing 1 mM phenylmethanesulfonyl fluoride (PMSF)
and protease inhibitor mixture (Sigma). After centrifugation at
10,000 ⫻ g for 30 min at 4 °C, cleared lysates were incubated
with a rabbit anti-Scc4 antibody (or with preimmune serum
from the corresponding rabbit) overnight at 4 °C. The
antigen䡠antibody complexes were then combined with protein
A/G-Sepharose (Pierce) and incubated for 60 min at 4 °C. Following extensive washing, the captured complex was eluted in
SDS sample buffer, separated by SDS-PAGE, and subjected to
immunoblotting.
Limited Proteolysis—Purified Scc4䡠Scc1-His6 complex or
Scc4 protein at concentrations of 1 mg/ml were digested with
trypsin (Promega) on ice and at 25 °C in 20 mM HEPES (pH 7.4)
and 125 mM NaCl. The ratio of enzyme to substrate was 1:100
(by weight). At different time intervals, aliquots were taken and
added immediately to an equal volume of 2⫻ SDS sample
buffer, boiled for 5 min to stop the proteolysis, and stored at
⫺20 °C. The samples were then analyzed on 4 –20% Tris-Tricine gels (Bio-Rad) and stained by Coomassie blue. Bands of
interest were then further proteolyzed at 37 °C with the combination of Glu-C (New England Biolabs) and trypsin (in a 10:1
(w/w) ratio) prior to mass spectroscopic analysis.
Protein Structure Prediction—The protein homology/
analogy recognition engine version 2.0 (Phyre2) (42) was used
to build three-dimensional structural models of CopN, Scc4,
and Scc1. Each protein was modeled individually using the
Phyre2 intensive option. The quaternary structural model of
CopN, Scc4, and Scc1 was made by aligning the individual models to their homologous proteins in the crystal structure of Yersinia pestis YopN䡠SycN䡠YscB complex (Protein Data Bank code
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1XKP) (43). The alignments were performed using the UCSF
Chimera software and the Match/Align function with an amino
acid residue distance cut-off of 3.0 Å, at most 10 iterations, and
superimposition across the entire alignment (44).
␤-Galactosidase (␤-gal) Assay—A plate ␤-gal assay (45) was
utilized to measure ␤-gal activity with mid-log phase E. coli
cultures.

Results
CopN Directly Complexes with Scc4 and Scc1 in Vitro and in
Situ—Direct evidence of CopN dynamically binding with Scc4,
Scc1, and/or Scc3 has not been previously reported for C. trachomatis. To investigate the details of these molecular interactions, we first determined which intermolecular associations
would occur in vitro using a His6-mediated pull-down assay.
Purified Scc4䡠Scc1-His6 protein complex was immobilized on
Ni2⫹-NTA beads and then incubated with purified GST-tagged
CopN and/or purified GST-tagged Scc3 as described under
“Materials and Methods.” Bound proteins were eluted, separated by SDS-PAGE, and detected by immunoblot with specific
antisera. Fig. 1A indicates that CopN binds directly to the
Scc4䡠Scc1 complex. There was no direct binding between the
Scc4䡠Scc1 complex and Scc3. We conclude that the Scc4䡠Scc1
complex associates with Scc3 only in the presence of CopN.
We next monitored the appearance of Scc4 and Scc1 in
C. trachomatis-infected HeLa cells using IFA with specific antibodies. Using the same culture model and IFA, we previously
reported that C. trachomatis accumulated detectable amounts
of CopN at and beyond 20 hpi (46). We observed an Scc4specific signal associated with chlamydial organisms at 16 hpi.
An Scc1-specific signal was not easily visualized prior to 20 hpi.
However, at 24 hpi, anti-Scc1 antibodies clearly labeled chlamydial organisms (Fig. 1B). The Scc1-positive organisms were
also reactive with anti-Scc4 antibodies. As inclusions expanded,
both Scc4- and Scc1-specific signals continued to increase
throughout the 44-h period of observation. These data indicate
the co-existence of Scc1 and Scc4 proteins at the late stage of
C. trachomatis infection in HeLa cells.
We asked whether, at the late growth stage, CopN associated
with Scc4 and Scc1 in C. trachomatis. Cross-linking with DSP
and co-immunoprecipitation assays were performed with
C. trachomatis-infected cells harvested at 36 hpi. In control
experiments, uninfected cells and ampicillin-exposed cells
were used. It is known that exposure of C. trachomatis to inhibitors of peptidoglycan synthesis, such as ampicillin, leads to the
formation of aberrant RBs that cannot differentiate to EBs (the
infectious late developmental form). Ampicillin exposure is
also known to down-regulate CopN expression (46). The
cleared lysates from the cross-linked cells were subjected to
immunoprecipitation with anti-Scc4 antibodies and then
immunoblotted with antibodies specific to Scc4, CopN, or
Scc1. No Scc4, Scc1, or CopN was immunoprecipitated by preimmune sera (not shown). As expected, we observed that antiScc4 antibodies immunoprecipitated Scc4 from the lysate of
C. trachomatis culture unexposed to ampicillin (Fig. 1C). CopN
and Scc1 were also co-precipitated with Scc4. However, CopN
appeared somewhat smeary, which is probably due to the heterogeneous labeling by the DSP cross-linking reagent. DSP is a
VOLUME 290 • NUMBER 47 • NOVEMBER 20, 2015
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FIGURE 1. CopN directly binds the Scc1䡠Scc4 complex or isolated Scc3. A, analysis of Scc4䡠Scc1-bound proteins using a His6-mediated pull-down
assay. Protein inputs are shown at the top (⫹), and pulled-down proteins (outputs) were probed with appropriate antibodies shown on the left. B, Scc4
and Scc1 co-localize during later stages of infection. Cells were fixed at 16, 20, 24, 36, and 44 h postinfection and processed for IFA. Shown are cells fixed
at 24 h postinfection. Scc1 and Scc4 proteins were probed with specific polyclonal antibodies and then visualized with fluorescent secondary antibodies. Scc1 and Scc4 were visualized as green and red, respectively. Host and bacterial DNA were visualized with DAPI staining (blue). Inclusions are
indicated by arrows. The co-localization of the two proteins (orange) within a selected inclusion (inset) is indicated by arrowheads. Scale bar, 10 m. C,
results of cross-linking; immunoprecipitation; and immunoblotting of Scc4, Scc1, and CopN. Representative blots from three individual experiments are
shown. DSP cross-linked cultures harvested at 36 hpi were subjected to immunoprecipitation with anti-Scc4 antibodies. The resultant protein䡠antibody
complexes were subjected to immunoblotting with antibodies specific to each protein. Mock infection HeLa cells and cells exposed to ampicillin were
used as controls.

reversible cross-linking reagent but not a cleavable reagent. A
3-mercaptopropionamide moiety remains at each cross-linked
lysine residue; CopN has 27 lysine residues, giving numerous
possible compositions. Little Scc4 was obtained from the cells
exposed to ampicillin, suggesting that ampicillin exposure
reduced Scc4 expression similar to CopN (46). Neither CopN
nor Scc1 was immunoprecipitated from the ampicillin-exposed
samples. Together with the IFA data (Fig. 1B), these data indicate that Scc4 binds to both Scc1 and CopN in the late stages of
C. trachomatis growth. Aberrant RBs induced by ampicillin
produce little CopN and Scc4 and are unable to form
Scc4䡠Scc1䡠CopN complexes.
Co-expression of Scc4 Promotes Scc1 Solubility in E. coli—To
facilitate the study of protein-protein interactions between
Scc4 and Scc1, either tag-free Scc4 alone or Scc4 with Scc1-His6
were expressed in E. coli BL21(DE3) cells. The levels and solubility of Scc4, Scc1-His6, or both proteins were examined (Fig.
2). Expression of Scc4 alone resulted in a highly soluble Scc4
protein, but expression of Scc1-His6 alone resulted in very low
levels of soluble protein (Fig. 2A). In contrast, co-expression of
Scc4 and Scc1-His6 led to a significant increase in soluble Scc1.
Using Ni2⫹ affinity chromatography, the Scc4 and Scc1-His6
remained together and co-eluted (data not shown). Further
purification by gel filtration chromatography demonstrated
that the Scc4䡠Scc1-His6 complex was obtained as a highly pure
protein species, as evidenced by SDS-PAGE and Coomassie
Blue staining (Fig. 2, B and C). The Scc4䡠Scc1-His6 complex
displayed protein bands of apparently equal relative intensities,
implying a stoichiometry of 1:1 and suggesting a heterodimer
complex. Identical results were obtained when N-terminal
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His6-tagged Scc4 (His6-Scc4) and the N-terminal FLAG-tagged
Scc1 were co-expressed. Neither the expression of Scc1 and
Scc4 nor the stoichiometry of Scc4䡠Scc1 complex was affected
by the location of affinity tags (N-terminal or C-terminal).
These data indicate that the solubility of Scc1 is dependent
upon co-expression of and binding to the Scc4 protein in E. coli.
Oligomeric States of Scc4 and the Scc4䡠Scc1 Complex in
Solution—Despite the observation of the Scc4䡠Scc1 heterodimer, most class I chaperones form homodimers for targeting the effectors (12). To determine whether Scc4 does form
homo-oligomers, we conducted a vapor glutaraldehyde crosslinking assay with purified Scc4 protein in vitro. Indeed, Scc4
does self-associate, as evidenced by SDS-PAGE analysis (data
not shown). We then sought to identify buffer conditions that
might influence the aggregation state of Scc4 in the presence or
absence of Scc1 to address the possibility that Scc4 self-aggregation might influence in vitro binding experiments with Scc1.
We also experimented with buffer conditions to determine
those appropriate for NMR analysis. Analytical gel filtration
chromatography was performed to study the aggregation states
of His6-Scc4 and Scc4䡠Scc1-His6 at various protein concentrations and under different buffer conditions (Fig. 3 and Table 1).
An apparent 1:1 molar ratio of eluting Scc4䡠Scc1-His6 species
was confirmed by SDS-PAGE analysis (data not shown). In
Tris-buffered saline at pH 8.0, His6-Scc4 (solid black line) predominantly exists as a homodimer with some higher order oligomers (⬎300 kDa) evident, whereas the Scc4䡠Scc1-His6 complex (dashed black line) mainly elutes as a stable tetramer (Fig.
3A), which is consistent with the tendency of Scc4 to dimerize
under these conditions. In acetate buffer at pH 4.5, both His6JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Protein expression, solubility analysis, and stoichiometry. A, expression levels and solubility analysis for Scc4, Scc1, and Scc4 ⫹ Scc1 co-expression in E. coli cells. Protein expression was induced with IPTG(⫹). Proteins from different fractions were analyzed by SDS-PAGE and Coomassie Blue staining. B,
gel filtration chromatography of the Scc4䡠Scc1-His6 complex. The Ni2⫹ column purified Scc4䡠Scc1-His6 complex was concentrated to 30 mg/ml. Sequential
dilutions were performed on the samples and subsequently loaded on a 26/60 Superdex 75 column equilibrated with buffer N (20 mM Tris (pH 7.6), 100 mM
NaCl, and 5% glycerol). The column was calibrated in buffer N using albumin (66 kDa), chicken ovalbumin (44 kDa), carbonic anhydrase (29 kDa), cytochrome
c (12.4 kDa), and vitamin B12 (1.35 kDa) as standards. C, analysis of selected 4-ml protein fractions on 12% SDS-PAGE with Coomassie Blue staining. Note that
the stoichiometry of the purified Scc4 and Scc1 protein complex appears to be 1:1.

FIGURE 3. Gel filtration reveals various oligomeric states of Scc4 and Scc4䡠Scc1 influenced by buffer conditions. A, HiPrep Sephacryl S-100 HR column
using 1-ml sample volumes. B, Enrich SEC 70 analytical column with 50-l sample volumes. Injected protein concentrations were in the range of 81–152 M
with the exception of the Scc4䡠Scc1 complex at pH 4.5 (27 M) due to its low solubility in this buffer (sample conditions are described in detail in Table 1). AU,
absorbance units.

Scc4 and the Scc4䡠Scc1-His6 complex were unstable. Under
these conditions (pH 4.5), His6-Scc4 alone was prone to precipitation. However, the Scc4䡠Scc1-His6 complex appeared to be
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somewhat more stable, with some soluble Scc4䡠Scc1-His6 complex evident as a heterodimer (solid gray line). In phosphate
buffer at pH 7.3, His6-Scc4 formed a homodimer (solid black
VOLUME 290 • NUMBER 47 • NOVEMBER 20, 2015
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TABLE 1
Conditions used in gel filtration analysis
Sample
Scc4 (152 M)
Scc4䡠Scc1 (133 M)
Scc4䡠Scc1 (27 M)
Scc4 (81 M)
Scc4 (81 M)

Sample volume
1 ml
1 ml
1 ml
50 l
50 l

Running buffer

Column

Results

20 mM Tris, 150 mM NaCl, pH 8.0
20 mM Tris, 150 mM NaCl, pH 8.0
20 mM sodium acetate, pH 4.5
50 mM sodium phosphate, pH 7.3
20 mM Tris, pH 7.4

HiPrep Sephacryl S-100 HR
HiPrep Sephacryl S-100 HR
HiPrep Sephacryl S-100 HR
ENrich 70 SEC
ENrich 70 SEC

Oligomer, dimer
Heterotetramer
Heterodimer
Dimer
Trimer

line); however, in Tris buffer at pH 7.4 (dashed black line), His6Scc4 surprisingly formed homotrimers (Fig. 3B). Because the
ionic strength of the 20 mM Tris buffer is about one-tenth that
of 50 mM phosphate buffer, whereas the pH of the two buffers is
nearly identical, it is likely that the homotrimers seen in the Tris
buffer are utilizing polar contacts to construct the trimer, and
these polar interactions are significantly weakened by the
higher ionic strength of the phosphate buffer. These results
indicate that at very close to physiological pH, Scc4 can exist as
a dimer or a trimer, depending on the ionic strength and perhaps the particular ion species.
We also observed the Scc4䡠Scc1-His6 complex eluting as a
heterotetramer in 20 mM Tris, 150 mM NaCl at pH 8.0 and as a
heterodimer in 20 mM sodium acetate at pH 4.5. In these experiments, there is a large difference in pH as well as differences in
ionic strength. Differences in pH will affect the protonation
state of surface amino acid residues involved in oligomerization, and ionic strength differences can affect polar
interactions.
Collectively, these data indicate that the buffer conditions
influence the oligomeric states of Scc4 and Scc4䡠Scc1 in vitro,
and because in general, hydrophobic interactions are less sensitive to ionic strength than polar interactions, variations in
oligomeric species seen here are modulated by polar interactions through ionic strength differences and the protonation
state of key amino acid side chains.
Slow Scc4 Exchange Occurs with the Scc4䡠Scc1 Heterodimer—
To gain insight into the binding parameters of Scc4 and Scc1,
we conducted a competition protein binding assay. Purified
Scc4䡠Scc1-His6 complex was incubated with an excess of
[15N]Scc4 at two different molar ratios, 2:1 and 10:1 ([15N]Scc4/
Scc4䡠Scc1-His6), in Tris buffer (pH 7.6) for either 0.5- or 2-h
time periods (Fig. 4A). The resultant Scc4䡠Scc1-His6 complex
was then isolated from free Scc4 protein using Ni2⫹ affinity
chromatography and subsequently subjected to SDS-PAGE
isolation. The proper protein bands were excised from the
gel and subjected to quantitative LC/MS analysis to determine the amount of [15N]Scc4 that had exchanged with unlabeled Scc4 protein from the Scc4䡠Scc1-His6 complex. Comparison of Coomassie Blue-stained bands on SDS-PAGE
corresponding to Scc4 and Scc1 indicated an apparent 1:1
stoichiometry (data not shown), showing that incubation
with excess Scc4 protein does not alter the stoichiometry of
the Scc4䡠Scc1 complex. Fig. 4, B and C, show that low levels
of [15N]Scc4 were exchanged with unlabeled Scc4 that was
prebound to Scc1-His6. Approximately 12.4% of Scc4 was
displaced by an excess of [15N]Scc4 when it was present at a
10-fold molar excess for a 2-h incubation period. An estimated 8.7% of prebound Scc4 was displaced when [15N]Scc4
NOVEMBER 20, 2015 • VOLUME 290 • NUMBER 47

was present at a 2-fold molar excess during the same 2-h
incubation period. Other Scc4 peptides showed similar
incorporation ratios. These data verify a slow exchange
between Scc4䡠Scc1-His6 and the Scc4.
Chemical Shift Analysis of the Scc4-Scc1 Interaction—1H-15N
HSQC NMR spectroscopy was used to monitor the competition between Scc4 homodimer formation and Scc4䡠Scc1-His6
heterodimer formation (Fig. 5). To this end, purified [15N]Scc4
(0.5 mM) in 20 mM ammonium acetate (pH 5.5) was analyzed
before and after the addition of unlabeled, purified Scc1-His6
added at a 1:1 molar ratio (see “Materials and Methods”). Fig. 5
shows an overlay of [15N]Scc4 alone and [15N]Scc4 in complex
with the Scc1-His6. The peak widths in both spectra are characteristic of a dimer (⬃30 kDa) rather than a monomer (⬃15
kDa), indicating that Scc4 alone forms a homodimer, and Scc4
in the presence of Scc1-His6 forms a heterodimer under these
conditions. The shifts of the NMR peaks correspond to changes
in the backbone structure of [15N]Scc4 upon binding Scc1-His6.
Of the 13 amide signals shown in the inset of Fig. 5, four show
little or no change in chemical shifts, and nine show varying
degrees of shifts, indicating local structural changes upon heterodimer formation. Because the peak intensities of Scc4 with
and without Scc1-His6 are approximately the same, and no
residual peaks occur at the Scc4 homodimer chemical shifts,
the Scc4䡠Scc1-His6 complex must have a significantly lower dissociation constant (Kd) compared with the Scc4 homodimer
complex, favoring formation of the Scc4䡠Scc1-His6 complex.
This observation is consistent with the low level of exchange
between Scc4䡠Scc1 and Scc4 observed in the protein competition assays (Fig. 4). Therefore, homo-oligomers of Scc4, which
presumably have a distinct function in the C. trachomatis
developmental cycle, can be disrupted by the presence of Scc1,
driving the formation of Scc4䡠Scc1 heterodimers, which presumably elicit their own unique effects.
Identification of a Region of Importance for Scc4䡠Scc1 Complex Formation Using Proteolysis—To define regions of each
protein that are involved in binding, the Scc4䡠Scc1 complex was
subjected to limited proteolysis coupled to LC/MS analysis (Fig.
6). Regions of the proteins that are involved in tight binding
should be resistant to proteolysis, whereas exposed, extraneous
sequences should be more susceptible to proteolytic cleavage.
In pilot experiments, the purified Scc4䡠Scc1 complex remained
relatively undigested by the narrow specificity protease, trypsin.
However, Scc4 protein alone was susceptible to proteolysis by
trypsin and was almost completely degraded over time. We
next examined Scc4䡠Scc1 complex peptides liberated by limited
digestion with trypsin. All tryptic products smaller than the
Scc4 molecular weight that were clearly visualized on Coomassie-stained Tricine-SDS-PAGE were subjected to digestion
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. Scc4 subunit exchange with the Scc4䡠Scc1 complex. A, procedural workflow schematic. Ratios of [15N]Scc4/[14N]Scc4䡠Scc1-His6 were either 2:1 or
10:1. B, representative stack plot of mass spectra from reactions (RXN) 1 and 2 containing Scc4 tryptic peptide (Met69–Arg96). The 14N and 15N forms of the
peptide MMEGNLFGQETGGAALGLDSDGHAVLVR (where M represents oxidized methionine) have exact masses of 2,876.3 and 2,912.0 Da. Because of the
charge (z ⫽ 3), their mass-to-charge ratios (m/z) are 959.8 and 971.4, respectively. Shown are the peptide ion spectra for 0.5-h (blue) and 2-h (red) incubations
with a 2:1 ratio of [15N]Scc4 to [14N]Scc4䡠Scc1-His6. Due to naturally existing isotopes (e.g. 13C) and sufficient resolution, peptide ions can be observed with an
interval of m/z 0.33 (1 Da/3, here z ⫽ 3). The first and the last peaks, indicated by arrows, represent the 14N and 15N peptide ion. C, summary of displacement rate
of [14N]Scc4 by [15N]Scc4.

FIGURE 5. Binding of Scc1 perturbs amide peaks of [15N]Scc4. Overlay of 1H-15N HSQC spectra of [15N]Scc4 (red peaks) and [15N]Scc4䡠Scc1-His6 complex (blue
peaks) that forms after the addition of a 1:1 molar ratio of Scc1-His6. The inset illustrates selected chemical shifts of glycine amide peaks upon binding Scc1-His6
(note that no peaks are covered by the inset).

with Glu-C protease and trypsin. The peptide bands marked by
arrows (Fig. 6B), which probably resulted from cleavage at the
most vulnerable regions, were subjected to LC/MS analysis.
Band A, stable through several time points, contained mostly
Scc1 with peptides arising from amino acid residues Arg31–
Leu146, implying that the Scc1 region bound by Scc4 was
located between Arg31 and the C terminus. Band B comprised
amino acid residues Arg40–Lys129 from Scc4. This result
implies that Scc1 protects Scc4 amino acid residues Arg40–
Lys129 from trypsin attack and that these amino acid residues
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(Arg40–Lys129) may be heavily involved in formation of the
Scc4䡠Scc1 heterodimer. Band C contained mostly Scc1 peptides
probably arising from degraded Scc1 released from partially
digested, destabilized Scc4䡠Scc1 complex. Similar treatment of
Scc4 with trypsin led to rapid, complete degradation of Scc4,
suggesting that Scc4 or its homo-oligomers may not be as stable
as the Scc4䡠Scc1 heterodimer under these experimental conditions. These data support the notion that Scc4䡠Scc1 is a stable
heterocomplex that is resistant to proteolysis. Fig. 6C illustrates
the Scc1 Arg31–Leu146 and Scc4 Arg40–Lys129 regions mapped
VOLUME 290 • NUMBER 47 • NOVEMBER 20, 2015
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FIGURE 6. Identifying the Scc4䡠Scc1 interface using limited proteolysis. A, amino acid sequences of Scc1 and Scc4 with lysine and arginine residues in red.
B, SDS-Tricine gel analysis of tryptic peptides. Samples were trypsinized at either 0 or 30 °C for 0 min, 240 min, or overnight (O.N.). Aliquots were electrophoresed on a 10 –20% SDS-Tricine gel, and fragment bands (indicated by red letters) were excised and digested further with Glu-C and trypsin. C, analysis delineates
a protease-resistant core region central to the Scc4-Scc1 interaction (blue, Scc4; orange, Scc1).

onto a homolog-based structural model of the Scc4䡠Scc1
heterodimer.
Role of Scc4 in Forming the C. trachomatis Scc4䡠Scc1䡠CopN
Complex—Although Scc4 and Scc1 are predicted to share
structural similarity to Yersinia SycN and YscB (23, 43), the
amino acid residues at the interface of this Yersinia heterodimer (that complexes with Yersinia YopN (homologous to
CopN)) are poorly conserved. We hypothesize that either Scc4
or Scc1 predominantly contacts CopN in the Scc4䡠Scc1䡠CopN
complex. To test this, we used a modified version of the bacterial two-hybrid (BTH) assay, referred to as a “bridge” BTH assay
(47). In this assay, an unfused bridging protein is expressed with
two fusion protein moieties that do not interact directly with
each other (Fig. 7A). One of these protein moieties is fused to
the CI protein (a sequence-specific DNA-binding protein),
and the other one is fused to the N-terminal domain of the ␣
subunit of RNAP (␣-NTD). Interaction of the bridging protein
with the two fused moieties results in the recruitment of RNAP
and activation of transcription from a test promoter (here placOL2-62), which drives the expression of a linked lacZ gene in
the reporter strain, FW102 OL2-62 (48) (Fig. 7A). Thus, tripartite protein-protein interactions can be detected by performing
the ␤-gal assays.
Attempts to make full-length CopN fused to the ␣-NTD or to
CI were unsuccessful. However, we were able to obtain a truncated version of CopN (missing 50 amino acid residues from its
C terminus) fused to the ␣-NTD, which we call ␣-CopN⌬C.
NOVEMBER 20, 2015 • VOLUME 290 • NUMBER 47

Various combinations of expression constructs (each directed
by an IPTG-induced promoter) were expressed in the reporter
strain. We found that the expression of Scc4 in the presence of
CI-Scc1 and ␣-CopN⌬C activated transcription from the test
promoter with an increase of ␤-gal up to 4.2-fold compared
with the non-induced control (Fig. 7B, lane 5). No significant
increase in ␤-gal activity was seen for the control strain carrying
empty vectors (Fig. 7B, lane 1). These results imply that Scc4
makes simultaneous contact with both Scc1 and the CopN⌬C
in the context of a Scc4䡠Scc1䡠CopN⌬C complex. Interestingly,
expression of unfused Scc1 did not enhance transcription in the
presence of ␣-CopN⌬C and CI-Scc4 (Fig. 7B, lane 6). This
suggests that Scc1 is unable to bridge interactions between Scc4
and CopN in the context of a Scc4䡠Scc1䡠CopN⌬C complex or
that Scc1 may not be stable. The latter possibility was ruled out
because immunoblotting showed that stable Scc1 was present
in the reporter strain co-expressing Scc1, ␣-CopN⌬C, and CIScc4 (Fig. 7C). Moreover, ␣-Scc1 interacted with CI-Scc4 (Fig.
7B, lane 2). Individually, neither the Scc4 as the CI-Scc4 fusion
protein nor the Scc1 as the CI-Scc1 fusion protein appeared to
interact with ␣-CopN⌬C (Fig. 7B, lanes 3 and 4). The individual
chaperones may not provide enough surface area to form a
sufficiently stable chaperone䡠CopN complex (to promote transcription from the test promoter). Alternatively, when Scc4 and
Scc1 bind each other, there may be a significant conformational
change and/or a significant stabilization of structural elements
required for tight binding to CopN.
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 7. Role of Scc4 in the Scc1䡠Scc4䡠CopN complex as determined by a bridge BTH assay. A, schematic detailing the essence of the assay. Stable
interactions between Scc1 (fused to the bacteriophage CI protein (CI)), CopN (fused to the N-terminal domain (␣-NTD) of the E. coli RNAP ␣ subunit), and the
non-fused Scc4 activate transcription from the test promoter placOL2-62, which bears the  operator OL2 centered 62 bp upstream of the lac core promoter
start site. In E. coli reporter strain FW102 OL2-62 (48), test promoter placOL2-62 is located on an F⬘ episome and drives the expression of a linked lacZ gene. B,
␤-gal assay results. The assays were performed with FW102 OL2-62 cells containing three compatible plasmids, the first one encoding either CI or a CI-Scc1
fusion protein, the second one encoding either ␣ or the ␣-CopN⌬C fusion protein, and the third one encoding full-length Scc4 protein that bridges the
chimeras (CI-Scc1 and ␣-CopN⌬C proteins). The plasmids that directed the synthesis of the proteins are controlled by IPTG-inducible promoters. The bacterial
cells were grown in the absence (white bars) or presence of 20 g of IPTG (gray bars). Note that CI-Scc1 and ␣-CopN⌬C proteins did not directly interact with
each other in the absence of Scc4 (lane 3). However, ␣-Scc1 directly interacts with the CI-Scc4 (lane 2). The interaction shown in lane 2 is used as a positive
control, and the empty vector-containing cells (lane 1) were used as negative controls for this system. C, induction of non-fused Scc1 protein by the addition
of increasing concentrations of IPTG (0, 10, 20, and 100 M) in the reporter strain (B, lane 6). Error bars, S.D.

Predicting the Structure of the Ternary Scc4䡠Scc1䡠CopN
Complex—In an attempt to visualize structural details required
for the stable ternary complex, a homology model of the
Scc4䡠Scc1䡠CopN complex was produced using the Phyre2 protein fold recognition server (42) (Fig. 8). The Scc4 and Scc1
structural models were made by Phyre2 using several homologous structures, including 1K3E chain A (E. coli CesT, Uniprot P58233) (49), 1TTW chain A (Y. pestis SycH, Uniprot
Q7BTX0) (50), 1JYO chain A (S. enterica SicP, Uniprot
P0CL16) (51), 4G6T chain A (Pseudomonas syringae ShcA,
Uniprot Q87UE6) (52), and 3EPU chain B (S. enterica
STM2138, Uniprot Q8ZNP3) (53). 99% of the structure for
amino acid residues 1–132 of Scc4 was modeled with ⬎90%
confidence. 93% of the Scc1 structure corresponding to amino
acid residues 1–136 was modeled with ⬎90% confidence. The
homology model of CopN was made using two template structures: 1XKP chain A (Y. pestis YopN amino acid residues
Gln33–Thr57 and Glu65–Gly269, UniProt P68640) (43) and 4P40
chain A (C. pneumoniae CopN, amino acid residues Leu96–
Asn383, UniProt Q9Z8L4) (30). 81% of CopN amino acid residues 37– 60 and 77–381 were modeled with ⬎90% confidence.
Protein Data Bank entry 1XKP is a complex of three proteins
(the Y. pestis plug protein YopN and two T3S class I chaperones, SycN and YscB), and these were used to arrange the
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C. trachomatis models with respect to each other. Alignment of
the CopN structure on YopN (from 1XKP) yielded two overlapping regions for the two structures corresponding to 18 CopN
amino acid residues (within amino acid residues Gln37–Ile60)
and 102 CopN amino acid residues (within amino acid residues
Thr77–Asn267). The RMSD for C␣ atoms after alignment of the
CopN Gln37–Ile60 region is 1.18 Å (18 amino acid residues), and
for the Thr77–Asn267 region it is 1.57 Å (102 amino acid residues). Scc4 and Scc1 were aligned with their counterparts from
the YopN䡠YscB䡠SycN complex. Scc4 aligned with YscB (110
amino acid residues, C␣ RMSD of 1.40 Å), and Scc1 aligned
with SycN (86 amino acid residues, C␣ RMSD of 1.51 Å). Note
that nearly all contacts with CopN in this model are provided by
one chaperone that is serving as the “bridging” chaperone. We
have modeled Scc4 as the bridging chaperone based on the
bridge BTH results (Fig. 7), but it should be noted that there is
no significant difference in the structure quality when the chaperone positions are reversed (Fig. 8). With the Scc4 structure
superimposed on SycN, 87 C␣ atoms align with an RMSD of
1.46 Å. Similarly, 104 Scc1 C␣ atoms superimpose on YscB with
an RMSD of 1.48 Å.
The Scc4䡠Scc1䡠CopN Complex Requires Tight Interactions
between Scc4 and Scc1—In the Scc4䡠Scc1䡠CopN model, six Scc4
amino acid residues (Glu63, Met70, Glu71, Phe75, Val95, and
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FIGURE 8. The predicted structures of CopN, Scc4, and Scc1 proteins and
interface conservation. A, the predicted quaternary structure of
Scc1䡠Scc4䡠CopN aligned with the YopN, YscB, and SycN quaternary structure
(brown, Protein Data Bank code 1XKP). Two segments of CopN were aligned
with YopN: the N-terminal fragment Gln37–Ile60 (purple) and Thr77–Asn267
(blue). Scc4 (green) is aligned with YscB as the bridging chaperone, and Scc1
(pink) is aligned with SycN. B, the predicted chaperone-effector interface
mapped on the model of CopN with the degree of sequence homology to
YopN mapped by color: identical residues (green), highly similar residues (yellow), and different residues (red). The Scc4 and Scc1 models were each made
by Phyre2 using several related bacterial protein structures (as detailed under
“Results”). Similar Phyre2 results gave us the CopN model. Once these three
Phyre models were in hand, we used the 1XKP ternary structure to position
our models relative to one another. Note that the sequence homology at the
modeled interface is poorly conserved for all proteins.

Arg97) lie within 5 Å of Scc1, defining a potential intermolecular
interface for these chaperones (Fig. 9A). Whereas Glu63, Met70,
Glu71, and Phe75 are positioned in the second ␣ helix, Val95 and
Arg97 are located in the third ␤ strand in the Scc4 model. All of
these amino acid residues fall within the Scc4䡠Scc1 core region
that is protected from proteolysis (Fig. 6). Taking advantage of
our ability to quantify specific interactions between Scc4, Scc1,
and CopN through the use of our bridge BTH assay, we introduced alanine substitutions at these amino acid residue positions, singly or in combination, as an initial step toward defining structural elements in Scc4 vital to Scc1 binding (Fig. 9B). If
the alanine substitutions negatively affect binding, the Scc4 and
Scc1 interaction will diminish and in turn, reduce binding to
CopN with a resulting decrease in transcription in the bridge
BTH assay.
We were able to obtain three Scc4 mutants (Scc4_6A,
Scc4_4A, and Scc4_95A) containing six, four, and one alanine
substitution, respectively (Fig. 9B). We observed that the
Scc4_6A mutant abolished interactions between CI-Scc1 and
␣-CopN⌬C, whereas Scc4_4A had a less dramatic effect in the
bridge BTH assays (Fig. 9C). Interestingly, a low level of
Scc4_95A induction appears to disproportionately enhance
transcription from the test promoter, whereas higher levels of
Scc4_95A induction do not proportionately increase transcription from the test promoter as compared with induction of
NOVEMBER 20, 2015 • VOLUME 290 • NUMBER 47

wild-type Scc4 (Fig. 9C). One possible explanation for this
observation is that both the Scc4-Scc1 and the Scc4-Scc4 interactions are strengthened by the V95A mutation. At low protein
levels, Scc4_95A finds and binds to Scc1 and vigorously promotes transcription, whereas at higher induction levels, formation of the Scc4_95A homodimer is favored, and there is little
net increase of “free” Scc4_95A protein that can bind to Scc1.
The alanine substitutions do not have a profound effect on protein stability because immunoblotting indicated that the
Scc4_95A protein was produced in an IPTG dose-dependent
manner and was apparently stable, similar to the wild-type Scc4
and other Scc4 alanine mutants (Fig. 9D).
To determine whether the alanine substitutions directly
affected the Scc4-Scc1 interaction, we assessed the affinity of
Scc4 mutants for Scc1 in the absence of CopN. The Scc1 and
His6-Scc4 or its derivatives were co-expressed in E. coli cells at
high levels, and the soluble Scc4䡠Scc1 complexes were obtained
using Ni2⫹-NTA affinity chromatography and analyzed by
SDS-PAGE. Unlike the wild-type Scc4䡠Scc1 complex that displayed an apparent stoichiometry of 1:1, the ratio of Scc1 to
Scc4_6A, Scc4_4A, or Scc4_95A was notably decreased (⬍1).
These results confirm decreased affinity of these Scc4 mutants
to bind with Scc1 (Fig. 9E). Because the Scc4 mutant proteins
were expressed at levels comparable with the wild-type Scc4
(Fig. 9E), the observed decrease is not a result of Scc4 protein
poor expression. The unbound Scc1 might not be soluble, as
observed above (Fig. 2A). The weakened Scc4_95A䡠Scc1 interaction provides an explanation for the decreased ␤-gal transcription observed in the bridge BTH assay (Fig. 9D). With two
independent experimental approaches, these data reveal the
importance of Scc4 amino acid residues Glu63, Met70, Glu71,
Phe75, Val95, and Arg97, for mediating Scc4 and Scc1
interactions.

Discussion
In this current study, we examined the dynamic Scc4, Scc1,
and CopN interactions as well as the sequence and structural
requirements governing these events. We have previously demonstrated a role for Scc4 in transcriptional regulation through
its interaction with the 66RNAP holoenzyme (17), and we now
expand the role of this protein in the T3S process by confirming
its requirement (along with Scc1), as a T3S chaperone, for
CopN binding. Our study extends the role of the chlamydial
Scc4䡠Scc1 interchaperone interaction for CopN recognition
(23). Thus, we provide a new paradigm for tight control of T3S
system function mediated by Scc4 and its associated proteins in
C. trachomatis.
Unlike many other bacteria that have their T3S system genes
clustered in dedicated pathogenicity islands in plasmids or
chromosome (7, 10, 54), C. trachomatis T3S system genes are
scattered throughout the chromosome (55). Whereas the Scc1
and CopN genes are adjacent to each other and co-transcribed,
the Scc4 gene is located in a distinct operon encoding T3S needle proteins, chaperones, and energetic CdsN ATPase. How
Scc4, Scc1, and CopN function in conjunction with the T3S
protein expression, apparatus assembly, and effector secretion
is unknown. Nevertheless, evidence that the Scc4䡠Scc1䡠CopN
complex is formed during the late developmental cycle suggests
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 9. Key alanine substitutions in Scc4 affect its interactions with Scc1 and CopN. A, the Scc4䡠Scc1䡠CopN homology model was used to delineate the
intermolecular surface for this heterodimeric complex. B, Scc4 interface amino acid residues Glu63, Met70, Glu71, Phe75, Val95, and Arg97 were chosen for alanine
substitutions; Scc4_6A and Scc4_4A mutants contain six and four alanine substitutions, respectively, whereas Scc4_95A has just the V95A mutation. Approximate locations for mutations are indicated. C, effects of alanine substitutions using the bridge BTH assay. Scc4, ␣-CopN⌬C, and CI-Scc1 protein expression was
induced using the indicated amounts of IPTG. An empty vector (pCDFlac) in place of Scc4 was used as a control. D, immunoblotting indicates that Scc4 mutants
were expressed in an IPTG-dependent manner. E, effect of Scc4 alanine substitutions on Scc1 solubility in co-expression experiments. Complex was purified
using an Ni2⫹ affinity column and analyzed by 15% SDS-PAGE with Coomassie Blue staining. Approximate Scc1/Scc4 ratios are indicated. Error bars, S.D.

that this complex may play a role in an early step of the infection
process. For example, this complex may act to ensure that
translocators are secreted prior to effectors, so that effectors
will be exported directly into the targeted host cells to promote
invasion, similar to that seen with their Yersinia spp. counterparts (16, 56).
Our study reveals that the Scc4䡠Scc1 complex is a tight interaction, which can form higher order oligomers under certain
buffer conditions. Scc4 also forms various oligomeric species
that are influenced by pH and ionic strength. Because the
Scc4䡠Scc1 complex is very stable, if both chaperones are present
at equal abundance, this species will prevail. Therefore, in order
for Scc4 to conduct its specific function, either it will need to be
expressed at a different time in the developmental cycle of
C. trachomatis, or Scc4 will need to be expressed at higher levels relative to Scc1. Evidence of the differential expression of the
Scc4, Scc1, and CopN genes or proteins during the developmental cycle has been documented (6, 17, 28, 46, 57). Despite
the technical challenges associated with tracking early protein
expression in C. trachomatis, we detected the accumulation of
Scc4 protein in HeLa cells at 16 hpi, which is significantly earlier
that the 20 hpi required to detect CopN and Scc1 using IFA
(46). Note that 20 hpi coincides with the start of the RB-to-EB
transition and the increasing accumulation of EBs.
In the absence of Scc1 and CopN, Scc4 performs at least one
independent function in C. trachomatis as a transcriptional
regulator via its interaction with 66 region 4 and the ␤-flap of
the RNAP (17). The current study is unable to directly answer

28152 JOURNAL OF BIOLOGICAL CHEMISTRY

whether the Scc4䡠Scc1䡠CopN complex forms after Scc4 dissociates from the 66RNAP. Presumably, when Scc1 and CopN
are synthesized, Scc4 is available and binds with Scc1, and the
two serve as chaperones for CopN. Based on the high affinity of
the complex, Scc1 may extract Scc4 protein from 66RNAP,
thereby suddenly halting its effect on transcription. It is also
possible that Scc4 is produced constitutively during the developmental cycle, early for transcriptional regulation activities
and later to bind and stabilize Scc1. However, if at the time of
Scc1 and CopN expression there was a significant excess of
Scc4 protein, free Scc4 protein might still function in transcriptional regulation while the majority of Scc4 protein was
involved in heteromer formation with Scc1. In C. trachomatis,
Scc4 seems to stably express as determined previously by
immunoblotting (17). The dual role of Scc4 (as a T3S chaperone
and as a transcriptional regulator) is mediated by the expression
and stability of Scc1. Clarifying the expression pattern and degradation of Scc1 may be critical to understanding the temporal
function of Scc4.
Our experimental results are consistent with a predicted
structure of the Scc4䡠Scc1䡠CopN complex (Fig. 8). In this
model, Scc4, like YscB, is positioned as the bridging protein,
making simultaneous contacts with both Scc1 and CopN. We
note that there is no significant difference in the predicted
structure quality when the Scc1 and Scc4 chaperone positions
are reversed, based on computational comparison of Scc4 with
SycN and Scc1 with YscB. This is because Scc1, Scc4, and the
Yersinia chaperones, SycN and YscB, are all structurally homoVOLUME 290 • NUMBER 47 • NOVEMBER 20, 2015
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logous, albeit demonstrating quite low sequence conservation.
However, our bridge BTH assay (Fig. 7) indicates that Scc4
bridges interactions between Scc1 and CopN and therefore
should occupy the position in the complex analogous to that
occupied by YscB in the 1XKP structure. Moreover, the limited
sequence homology present apparently involves amino acid
residues that comprise the hydrophobic core of the proteins
and not surface amino acid residues that would mediate quaternary interactions. Another explanation for the observed
lack of sequence homology at the protein interfaces is the
fact that chaperones are typically very specific, and an equivalent protein from one species cannot bind the T3S system
substrate effector of another species (12). For instance, the
expression of C. pneumoniae Scc4, but not C. trachomatis
Scc4, enhances C. pneumoniae CopN secretion in Yersinia.5
The Scc3 from Chlamydophila psittaci binds the CopN
equivalent from C. pneumoniae but not C. trachomatis
CopN (27).
Using limited proteolysis, we found that the Scc4 C terminus
and the central region of Scc1 were required for Scc4䡠Scc1
interaction. Moreover, Scc4 amino acid residues important for
the Scc4-Scc1-CopN interaction were identified using alanine
substitutions, the bridge BTH assays, and affinity chromatography. Our data indicate that acidic amino acid residues (Glu63
and Glu71) and hydrophobic amino acid residues (Met70, Phe75,
and Val95) in Scc4 are required for tight binding to Scc1. Hydrophobic and electronegative surfaces have been implicated in
T3S chaperone function in effector recognition, synthesis, and
stability as reported previously (12, 43, 58). Because CopN only
binds the Scc1䡠Scc4 complex and not the individual Scc1 or
Scc4 proteins, formation of the Scc1䡠Scc4 complex is required
prior to binding of CopN. It is possible that, rather than simply
increasing the size of the CopN binding surface, the Scc4 and
Scc1 interaction triggers a conformational change in the chaperones that alters the quality of the bimolecular surface presented to CopN. Our data suggest that in the presence of Scc1,
Scc4 will form the Scc4䡠Scc1 heterodimer; in the absence of
Scc1, Scc4 can interact with 66RNAP and may do so as a
homodimer. To better understand the details of its interactions
with 66 and the ␤-flap of RNAP, further mutational studies of
Scc4 are warranted. These will provide a more complete understanding of how Scc4 exerts distinct functions in both transcription and the T3S process.
Our findings that Scc4 acts as both a chaperone for CopN
and a transcriptional regulator via direct interaction with 66
and the ␤-flap of RNAP suggest that the T3S system activity is
intimately linked to gene expression events in C. trachomatis.
We have developed a working model that depicts how T3S system activation or effector secretion might influence gene
expression (Fig. 10). Chlamydia-host cell contact induces
CopN dissociation from Scc4 and Scc1 through an as yet
unidentified mechanism, followed by CopN secretion. The liberated Scc4 and/or host cell contact-induced de novo synthesis
of Scc4 would then allow Scc4 to interact with the 66RNAP. In
turn, the Scc4䡠66RNAP holoenzyme selectively modulates

5

G. Plano, personal communication.
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FIGURE 10. Schematic highlighting the role of Scc4 as a T3S chaperone
and transcription regulator. A, chaperones Scc1, Scc4, and/or Scc3 stabilize
CopN as a “plug” in the secretion machinery, blocking all effector secretion
until proper signals arrive. B, host cell contact induces CopN secretion (followed by other effectors), freeing up Scc4 to perform its transcription regulation duties by targeting 66-RNAP. PM, host plasma membrane; OM/IM, bacterial outer and inner membrane.

transcription in a promoter-specific manner. This hypothetical
model gives a rationale for future studies to clarify the relationship between T3S system activation and gene expression during
C. trachomatis infection.
The detailed configuration of the binding interfaces involved
in forming the Scc4䡠Scc1䡠CopN complex or the Scc4䡠66䡠␤-flap
(of RNAP) complex will remain a puzzle until structural data is
provided. Meanwhile, our results provide a foundation for further investigations of the mechanisms that triggers T3S system
activation essential for infection progression. Recently, rapid
progress has been made toward the development of genetic
tools for studying the expression and localization of proteins
from C. trachomatis (59 – 62). These and other advances may
ultimately promote the elucidation of the mechanisms underlying the regulation of the T3S system in C. trachomatis.
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